一种抗心肌纤维化的四肽N-乙酰-丝氨酰-天冬氨酰-赖氨酰-脯氨酸
出处
《中华高血压杂志》
CAS
CSCD
北大核心
2007年第6期453-455,共3页
Chinese Journal of Hypertension
参考文献16
-
1[1]Cavasin MA,Rhaleb NE,Yang XP,et al.Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP[J].Hypertension,2004,43:1140-1145.
-
2[2]Rousseau-Plasse A,Lenfant M,Potier P,et al.Catabolism of the hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro:a new insight into the physiological role of the angiotensin-I -converting enzyme N-active site[J].Bioorg Med Chem,1996,4:1113-1119.
-
3[3]Van der Meer P,Lipsic E,Westenbrink BD,et al.Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure[J].Circulation,2005,112:1743-1747.
-
4[4]Junot C,Gonzales MF,Ezan E,et al.RXP 407,a selective inhibitor of the N-domain of angiotensin I-converting enzyme,blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis[J].J Pharmacol Exp Ther,2001,297:606-611.
-
5[5]Azizi M,Junot C,Ezan E,et al.Angiotensin I -converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline[J].Clin Exp Pharmacol Physiol,2001,28:1066-1069.
-
6[6]Rhaleb NE,Peng H,Yang XP,et al.Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney,1-clip hypertension[J].Circulation,2001,103:3136-3141.
-
7[7]PengH,Carretero OA,RaijL,et al.Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats[J].Hypertension,2001,37:794-800.
-
8[8]Cingolani OH,Yang XP,Liu YH,et al.Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats[J].Hypertension,2004,43:1067-1073.
-
9[9]Peng H,Carretero OA,Vuljaj N,et al.Angiotensin-converting enzyme inhibitors:a new mechanism of action[J].Circulation,2005,112:2436-2445.
-
10[10]Yang F,Yang XP,Liu YH,et al.Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction[J].Hypertension,2004,43:229-236.
-
1赵冬梅,蒋丹娜,杨伟光.思他宁治疗肝硬化食管胃底静脉曲张破裂出血79例临床疗效分析[J].哈尔滨医药,2006,26(1):45-46.
-
2陈静桂.伍用氨酰心安治疗充血性心衰的临床观察[J].华夏医学,1997,0(3):10-11.
-
3孙凌,袁志昌,杨吉成,吕海涛,严文华,盛伟华,丁云芳,王红英.牛磺酸抑制新生大鼠心肌成纤维细胞胶原合成及其机制的初步研究[J].苏州大学学报（医学版）,2003,23(3):298-300. 被引量：3
-
4郑蕊,申雪峰.心血管疾病诊治的新指标-B型钠尿肽（BNP）[J].健康必读（下）,2011(6):442-442.
-
5曹蕾,刘乃丰.他汀类药物干预心肌纤维化的机制[J].东南大学学报（医学版）,2012,31(4):496-500. 被引量：6
-
6胡玉琼,李家富.BNP在心力衰竭中的研究进展[J].深圳中西医结合杂志,2015,25(2):193-194.
-
7陈源文,董国芳,徐雷鸣,刘博伟,陈颖伟,李定国.内源性AcSDKP及其前体胸腺素β4在四氯化碳致肝纤维化发生早期的变化[J].胃肠病学和肝病学杂志,2010,19(1):6-9. 被引量：5
-
8葛云,李密,孙文林,蔡志基.纳洛酮治疗海洛因中毒的病例报告[J].中国药物依赖性通报,1993,2(2):137-137.
-
9王晓梅,王春丁.急性胰腺炎的治疗选择—附142例临床分析[J].现代消化及介入诊疗,2004,9(4):229-229.
-
10丰庆春,刘翔.胸腺素β4对大鼠心肌缺血再灌注损伤的保护作用[J].医学临床研究,2011,28(1):68-70.
